Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Neha Pagidipati
Research Area(s) / Expertise: Job title: Assistant Professor of Medicine
Neha J Pagidipati is an Assistant Professor of Medicine and cardiovascular disease prevention specialist. Since 2011, she has conducted research on cardiometabolic disease prevention, lifestyle modification and weight management. She is currently an NIH K12 scholar in Implementation and Dissemination Science. Dr Pagidipati is building the Duke Cardiometabolic Disease Prevention Program, which… View more
Understanding the Role of GLP-1 RAs in the Treatment of HF
Author(s): Giovanni Battista Bonfioli , Matteo Pagnesi , Daniela Tomasoni , et al Added: 10 months ago

Cardiovascular Kidney Metabolic

Heart Failure
ADA 2026 Scientific Sessions
Start date: Jun 05, 2026 End date: Jun 08, 2026
The American Diabetes Association's 86th Scientific Sessions are set to take place from 5th to 8th June 2026 at Ernest N. Morial Convention Center in New Orleans, LA. View more

Cardiovascular Kidney Metabolic
GLP-1RA in Different HFpEF Phenotypes
Author(s): Aleksandra Bykova , Maria Serova , Maria Chashkina , et al Added: 1 year ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Primary Care Process Curbs Population Weight Gain
Added: 5 months ago Source:  Radcliffe CVRM
A pragmatic, scalable approach to obesity implemented in primary care has the potential to curtail population weight gain, according to findings from the PATHWEIGH trial. The study found that a multi-component care process successfully mitigated the weight gain observed with usual care and increased the likelihood of patients receiving weight-related treatment.¹The PATHWEIGH intervention… View more

Cardiovascular Kidney Metabolic

Digital Health
Research Area(s) / Expertise: Job title: Cardiologist
Dr Chiadi Ndumele is a Cardiologist at The Johns Hopkins Hospital, Maryland, US and the Robert E. Meyerhoff Assistant Professor in the Department of Medicine at Johns Hopkins University.Dr Ndumele's research focuses on the relationship between obesity and cardiovascular disease, particularly heart failure. View more
Research Area(s) / Expertise: Job title: PhD, RD, FHFSA, FASPEN
Dr Salvatore Carbone, PhD, RDN, MS, FHFSA, FASPEN is an Associate Professor and Program Director of the Nutrition Program at the EVMS School of Health Professions, and an Associate Professor within the EVMS Division of Endocrine and Metabolic Disorders, Strelitz Diabetes Center, Department of Internal Medicine, at the Macon & Joan Brock Virginia Health Sciences at Old Dominion University… View more
ENDO 2025
Start date: Jul 12, 2025 End date: Jul 15, 2025
ENDO 2025 will take place on July 12th to 15th 2025 in San Francisco at the Moscone Convention Center. ENDO 2025 will host over 7,000 attendees with nearly 2,500 abstracts, and the sessions are set to cover obesity, diabetes, endocrine-disrupting chemicals, growth hormones, thyroid conditions, reproductive health, endocrine cancers, and much more. View more
SELECT: Semaglutide Reduces Hospital Admissions
Added: 5 months ago Source:  Radcliffe CVRM
Following the primary analysis of the SELECT trial, which demonstrated that semaglutide reduces major adverse cardiovascular events, a new exploratory analysis suggests the treatment also significantly lowers the rate and duration of hospitalisations in patients with established cardiovascular disease (CVD) and overweight or obesity, but without diabetes.¹MethodologyThis prespecified exploratory… View more

Cardiovascular Kidney Metabolic

Demographic